Dave Muoio

This week virtual care provider Teladoc Health was busy, releasing news about a new product launch and a separate good will initiative.

Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing.

Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public.

Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.

A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.

In May, a pair of studies were published in the journals Autism Research and the Journal of the American Medical Informatics Association (JAMIA) that evaluated Cognoa’s artificial intelligence-based tool for early identification of autism in children.

23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports.

Psychiatry has long stood as one of the more subjective areas of care, but new technologies and large-scale data generation and analysis may offer a more quantifiable approach to mental health treatment.

As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that offer improved treatment for serious diseases.

Omkar Kulkarni, innovation chief at Children's Hospital Los Angeles, says adoption of tech requires commitment.